Study on anti-breast cancer effect of paclitaxel palmitate and irinotecan hydrochloride co-encapsulated liposomes

Key Points

• The co-encapsulated liposomes show significant anti-cancer effects against breast cancer lesions, enhancing treatment outcomes.
• The combination therapy results in improved pharmacokinetics when compared to standard treatments.
• Assessment using co-encapsulation techniques indicates a better delivery of drugs to target cells, maximizing efficacy.
• Further validation in clinical settings is necessary to explore long-term impacts of this therapy on diverse breast cancer types.